Healthtech is predicted to focus on artificial intelligence (AI) and virtual care in 2022, with medical robotics not far behind, according to GlobalData’s latest report “Tech, Media & Telecoms Predictions 2022—Thematic Research.” The healthcare segment of the AI platforms market is set for growth, with a predicted rise from $1.6 billion in 2019 to $5.7 billion in 2025. However, regulation around the use of AI in healthtech, particularly for medical devices, is still in development.
Data and analytics company GlobalData predicts that AI will be a key driver of healthcare innovation and industry disruption in 2022. Digital and virtual tools will help to address the demand for better patient care and, although the sector of medical robotics holds promise, high costs will prevent quick adoption.
Jemima Walker, Analyst in the Thematic Research team at GlobalData, offers her view on the future of healthtech. According to her, AI has the potential to revolutionize the healthcare industry, supporting the shortening of drug discovery timelines, the successful repurposing of existing drugs to fight Covid-19, the enhancing of remote patient monitoring tools, the improving of supply chain efficiency, and the modernization of the outdated clinical trial model through improving trial design, patient recruitment, and patient retention. She said:
“The tech has already got companies talking, as mentions of ‘AI’ within healthcare, pharma, and medical device company filings increased by over 50%, from 700 in 2018 to 1,100 in 2021, according to GlobalData’s Filings Analytics Database. As more businesses realize the potential of incorporating AI into their day-to day-operations, the healthcare segment of the AI platforms market is set for growth, with GlobalData forecasts predicting a rise from $1.6 billion in 2019 to $5.7 billion in 2025. However, regulation around the use of AI in healthtech, particularly for medical devices, is still in development. The EU’s plans for additional more stringent requirements in 2022 will lead to large penalties for those that do not comply, and smaller companies will be prevented from entering the market entirely.
Digital and Virtual Tools
According to Jemima Walker, digital and virtual tools will help to address the demand for better patient care. She said:
“Traditional healthcare is transforming into a patient-centric, consumer-led model, as education, internet access, and wearable devices are allowing patients to actively participate in their medical journey. As the pandemic eases, virtual care will still be in demand. However, virtual care will need to take on a different form than simply ‘replacing in-person visits’, through a combination of both in-person and virtual interactions, with 24% of respondents stating they would be using both services following the Covid-19 pandemic.
She explained that the development of technologies such as 5G, augmented reality (AR), cybersecurity, autonomous vehicles and cloud computing will allow healthcare providers to fully embrace the transition into digitalized services. She added:
“There are opportunities for digital and virtual tools to help in many healthcare services, including mental health treatments, chronic pain management, stroke rehabilitation, opioid addiction therapy and even in the development of autonomous, connected ambulances.
The High Costs of Medical Robots
Jemima Walker also said that medical robotics holds promise, particularly for surgical inventions, but high costs prevent quick adoption. She explained:
“Medical robotics is a fast-growing field, with the surgical robotics segment leading the market. While Covid-19 caused the cancellation of an estimated 15% to 30% of elective surgeries from April 2020, there will still be 3.7 million robotic surgical procedures in 2022. However, the high costs of medical robots, and the additional training often required, will prevent quick, widespread adoption. Instead, for-profit entities will act as early leaders—particularly in the outpatient ‘same day’ surgery center sector. Early adopters will then lead to an explosion of adoption within hospitals and more public-based healthcare systems.”
